CM Hospitalar S/A

VVEO3

BRVVEOACNOR0

Pharmaceuticals

Delayed Sao Paulo Other stock markets 11:45:26 2024-05-03 am EDT			5-day change	1st Jan Change
5.25 ^BRL	-17.62%		-4.21%	-62.51%

Mar. 26	CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 26	CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

CM Hospitalar S/A(BOVESPA:VVEO3) added to S&P Global BMI Index

December 20, 2021 at 12:00 am EST

Latest news about CM Hospitalar S/A

CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 25	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index	Dec. 29	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A acquired remaining stake in Far.me.	23-02-05	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.	22-08-23	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions	22-06-08	RE
CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.	22-05-10	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-09	CI
CM Hospitalar S/A acquired Boxifarma.	22-04-18	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-10	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to S&P Global BMI Index	21-12-20	CI
CM Hospitalar S/A acquired Macromed Produtos Hospitalares Ltda.	21-11-15	CI
CM Hospitalar S/A entered into Purchase and Sale agreement to acquire Laborsys Produtos Produtos e Hospitalares Ltda.	21-11-11	CI
CM Hospitalar S/A has completed an IPO in the amount of BRL 1.87698 billion.	21-08-06	CI
CM Hospitalar S/A has filed an IPO.	21-02-03	CI

CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for CM Hospitalar S/A

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.03 BRL

Average target price

16.51 BRL

Spread / Average Target

+228.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CM HOSPITALAR S/A	-62.51%	315M
MCKESSON CORPORATION	+12.74%	69.68B
CARDINAL HEALTH, INC.	-2.10%	25.05B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.21B
HUADONG MEDICINE CO., LTD	-20.55%	7.96B
SINOPHARM GROUP CO. LTD.	-4.06%	7.75B
H. LUNDBECK A/S	+2.26%	4.64B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	+0.48%	4.09B
GALENICA AG	-3.02%	3.82B

Pharmaceuticals Wholesale

CM Hospitalar S/A

Equities

VVEO3

BRVVEOACNOR0

Pharmaceuticals

CM Hospitalar S/A(BOVESPA:VVEO3) added to S&P Global BMI Index

Latest news about CM Hospitalar S/A

Chart CM Hospitalar S/A

Company Profile

Income Statement Evolution

Ratings for CM Hospitalar S/A

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Pharmaceuticals Wholesale